Reply: “Toward a more translational SS-ILD model: Sex differences, endpoints, and B cell targets”

Xiuping Liang

Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, Sichuan,

Yanhong Li

Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Institute of Physical Chemistry, College of Chemistry and Materials Science

Deying Huang

Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, Sichuan,

Xueting Zhao

Yinlan Wu

Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, Sichuan,

Ronghui Liao

Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, Sichuan,

Tong Wu

Ziyi Tang

Chunyu Tan

Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, Sichuan,

Lu Cheng

Yubin Luo

Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, West China Hospital, Sichuan University , Chengdu, Sichuan,

Yi Liu